These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 998569)

  • 1. Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical procedures.
    Lipinska I; Lipinski B; Gurewich V; Hoffmann KD
    Am J Clin Pathol; 1976 Dec; 66(6):958-66. PubMed ID: 998569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen heterogeneity in homozygous plasminogen deficiency type I: further evidence that plasmin is not involved in formation of LMW- and LMW'-fibrinogen.
    Dempfle CE; Pfitzner SA; Schott D; Niessen KH; Heene DL
    Thromb Haemost; 1997 May; 77(5):879-83. PubMed ID: 9184396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma.
    Holm B; Nilsen DW; Kierulf P; Godal HC
    Thromb Res; 1985 Jan; 37(1):165-76. PubMed ID: 3983897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of the three normally-occurring plasma fibrinogens in health and during so-called "acute phase" by SDS electrophoresis of fibrin obtained from EDTA-plasma.
    Holm B; Godal HC
    Thromb Res; 1984 Aug; 35(3):279-90. PubMed ID: 6431629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal fibrinogen heterogeneity and fibrinolytic activity in advanced liver disease.
    Lipinski B; Lipinska I; Nowak A; Gurewich V
    J Lab Clin Med; 1977 Jul; 90(1):187-94. PubMed ID: 406338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of human blood platelets with three circulating plasma fibrinogens of different molecular weights.
    Thorsen LI; Holm B; Brosstad F; Solum NO
    Thromb Res; 1987 Sep; 47(6):683-92. PubMed ID: 3686483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The viscosity of fibrinogen subfractions and of EDTA denatured fibrinogen do not differ from that of native fibrinogen.
    Jensen T; Halvorsen S; Godal HC; Sandset PM; Skjønsberg OH
    Thromb Res; 2004; 113(1):51-6. PubMed ID: 15081565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular weight fibrinogen variants alter gene expression and functional characteristics of human endothelial cells.
    Weijers EM; van Wijhe MH; Joosten L; Horrevoets AJ; de Maat MP; van Hinsbergh VW; Koolwijk P
    J Thromb Haemost; 2010 Dec; 8(12):2800-9. PubMed ID: 20946180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of magnesium on fibrin formation from lower molecular weight (LMW) fibrinogen.
    Lipinski B; Lipinska I
    Magnes Res; 2000 Dec; 13(4):233-7. PubMed ID: 11153893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that changes in fibrinogen quality during acute phase reactions are of major importance for the amount of heparin precipitable fraction (HPF).
    Holm B; Godal HC
    Thromb Res; 1985 Aug; 39(4):449-58. PubMed ID: 4049325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancy between fibrinogen concentrations determined by clotting rate and clottability assays during the acute-phase reaction.
    Jensen T; Halvorsen S; Godal HC; Sandset PM; Skjøonsberg OH
    Thromb Res; 2000 Dec; 100(5):397-403. PubMed ID: 11150581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excercise-induced fibrinolytic activity and its effect on the degradation of fibrinogen, fibrin and fibrin-like precipitates.
    Gurewich V; Lipinska I; Lipinski B
    Thromb Res; 1974 Nov; 5(5):647-56. PubMed ID: 4445987
    [No Abstract]   [Full Text] [Related]  

  • 13. Postoperative plasma interleukin-6 in patients with renal cancer correlates with C-reactive protein but not with total fibrinogen or with high molecular weight fibrinogen fraction.
    Adler G; Eichman W; Szczepanski M; Targonska I; Jasinska A
    Thromb Res; 1998 Mar; 89(5):243-8. PubMed ID: 9645918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Half life and incorporation into venous thrombi of the normally occurring plasma fibrinogen fractions HMW and LMW.
    Holm B; Nilsen DW; Godal HC
    Thromb Res; 1986 Jan; 41(1):57-66. PubMed ID: 3961727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of alphaA-crystallin from high molecular weight aggregates in the normal human lens.
    Fujii N; Awakura M; Takemoto L; Inomata M; Takata T; Fujii N; Saito T
    Mol Vis; 2003 Jul; 9():315-22. PubMed ID: 12847419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased high molecular weight fibrinogen in pre-eclampsia.
    Manten GT; Sikkema JM; Franx A; Hameeteman TM; Visser GH; de Groot PG; Voorbij HA
    Thromb Res; 2003; 111(3):143-7. PubMed ID: 14678811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays.
    de Maat MP; Nieuwenhuizen W; Knot EA; van Buuren HR; Swart GR
    Thromb Res; 1995 May; 78(4):353-62. PubMed ID: 7631315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A local uPAR-plasmin-TGFβ1 positive feedback loop in a qualitative computational model of angiogenic sprouting explains the in vitro effect of fibrinogen variants.
    Boas SEM; Carvalho J; van den Broek M; Weijers EM; Goumans MJ; Koolwijk P; Merks RMH
    PLoS Comput Biol; 2018 Jul; 14(7):e1006239. PubMed ID: 29979675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease.
    Woodburn KR; Lowe GD; Rumley A; Love J; Pollock JG
    Int Angiol; 1995 Sep; 14(3):219-25. PubMed ID: 8919237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.